書誌事項
- タイトル別名
-
- Side Effect of Tobramycin Administered Via a Nasal Nebulizer
- トブラシン ノ ビ ネブ ライザー リョウホウ ノ ケントウ ソノ アンテイセ
- その安全性に関して
この論文をさがす
抄録
Tobramycin was administered nasally via a nebulizer and the tobramycin activity in the serum was examined.<br>In normal persons who received tobramycin nasally of 17.5mg, 35mg or 70mg, the activity of tobramycin in their serum was 0μg/ml or 0.3μg/ml. In patients with chronic sinusitis receiving tobramycin of 17.5mg several times (from 5 to 71 times), the serum concentrations were also 0 or 0.3μg/ml. No patients, receiving tobramycin complained of the symptoms due to its toxicity and nobody showed abnormalities in various examinations.<br>It is, therefore, conclude that it is safe to use tobramycin by means of a nasal nebulizer.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 75 (11), 2219-2223, 1982
耳鼻咽喉科臨床学会
- Tweet
キーワード
詳細情報
-
- CRID
- 1390001204264846720
-
- NII論文ID
- 130001814165
-
- NII書誌ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL書誌ID
- 2617479
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可